Cointime

Download App
iOS & Android

GenSight Biologics

company
Funding Round
Post-IPO Debt
Money Raised
€ 35M
Propotion
-
Post Valuation
-

Current Round Investors

Investor Name Invest Money Lead Investor Propotion
European Investment Bank - Yes - Detail

Historical Financing

Announced Date Round Money Raised Investors
Apr 8, 2013 Series A € 32M Versant Ventures Detail
Jul 23, 2015 Series B $ 36M Versant Ventures Detail
Dec 20, 2019 Post-IPO Debt € 15M Kreos Capital,3sbio Detail